Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 521-48-2
2. Isoxanthohumol(sophora)
3. 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
4. Chembl492828
5. 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one
6. (+/-)-isoxanthohumol
7. Unii-b3bxq4ezd6
8. 5-methylsophoraflavanone B
9. Schembl904557
10. Hy-n2584a
11. Chebi:171798
12. Isoxanthohumol, >=99% (hplc)
13. Isoxanthohumol, Analytical Standard
14. (2s)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
15. Bcp23864
16. Bdbm50252521
17. Lmpk12140553
18. Smp2_000215
19. Ncgc00390429-01
20. 4',7-dihydroxy-5-methoxy-8-prenylflavanone
21. Cs-0064440
22. 4',7-dihydroxy-5-methoxy-8-c-prenylflavanone
23. Q6086616
24. Isoxanthohumol, Primary Pharmaceutical Reference Standard
25. 7-hydroxy-2-(4-hydroxy-phenyl)-5-methoxy-8-(3-methyl-but-2-enyl)-chroman-4-one
26. 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one
27. 4h-1-benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methyl-2-butenyl)-
28. 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methyl-2-butenyl)-2,3-dihydro-4h-chromen-4-one #
Molecular Weight | 354.4 g/mol |
---|---|
Molecular Formula | C21H22O5 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 354.14672380 g/mol |
Monoisotopic Mass | 354.14672380 g/mol |
Topological Polar Surface Area | 76 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 519 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Isoxanthohumol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoxanthohumol, including repackagers and relabelers. The FDA regulates Isoxanthohumol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoxanthohumol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Isoxanthohumol supplier is an individual or a company that provides Isoxanthohumol active pharmaceutical ingredient (API) or Isoxanthohumol finished formulations upon request. The Isoxanthohumol suppliers may include Isoxanthohumol API manufacturers, exporters, distributors and traders.
Isoxanthohumol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isoxanthohumol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isoxanthohumol GMP manufacturer or Isoxanthohumol GMP API supplier for your needs.
A Isoxanthohumol CoA (Certificate of Analysis) is a formal document that attests to Isoxanthohumol's compliance with Isoxanthohumol specifications and serves as a tool for batch-level quality control.
Isoxanthohumol CoA mostly includes findings from lab analyses of a specific batch. For each Isoxanthohumol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isoxanthohumol may be tested according to a variety of international standards, such as European Pharmacopoeia (Isoxanthohumol EP), Isoxanthohumol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isoxanthohumol USP).
LOOKING FOR A SUPPLIER?